Defining the needs of patients with recurrent and/or metastatic head and neck cancer : An expert opinion
Copyright © 2020 Elsevier B.V. All rights reserved..
The clinical and biological heterogeneity of head and neck cancer (HNC) is paralleled by a plethora of different symptoms that affect the patient's quality of life. These symptoms include, for instance, pain, fatigue, nutritional issues, airways obstruction, voice alterations and psychological distress. In addition, patients with HNC are prone to a high risk of infection, and may also suffer from acute complications, such as hypercalcemia, spine compression by bone metastasis or bleeding. Prolonging survival is also an inherent expectation for all patients. Addressing the above needs is crucial in all patients with HNC, and especially in those with recurrent and/or metastatic (RM) disease. However, research on how to address patients' needs in RM-HNC remains scarce. This paper defines patients' needs for RM HNC and presents an Expert Opinion on how to address them, proposing also some lines of research.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:157 |
|---|---|
| Enthalten in: |
Critical reviews in oncology/hematology - 157(2021) vom: 30. Jan., Seite 103200 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Oliveira, Thiago Bueno [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Head and neck cancer |
|---|
| Anmerkungen: |
Date Completed 22.01.2021 Date Revised 22.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.critrevonc.2020.103200 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31886293X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31886293X | ||
| 003 | DE-627 | ||
| 005 | 20231225170239.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.critrevonc.2020.103200 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1062.xml |
| 035 | |a (DE-627)NLM31886293X | ||
| 035 | |a (NLM)33321152 | ||
| 035 | |a (PII)S1040-8428(20)30336-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Oliveira, Thiago Bueno |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Defining the needs of patients with recurrent and/or metastatic head and neck cancer |b An expert opinion |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.01.2021 | ||
| 500 | |a Date Revised 22.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier B.V. All rights reserved. | ||
| 520 | |a The clinical and biological heterogeneity of head and neck cancer (HNC) is paralleled by a plethora of different symptoms that affect the patient's quality of life. These symptoms include, for instance, pain, fatigue, nutritional issues, airways obstruction, voice alterations and psychological distress. In addition, patients with HNC are prone to a high risk of infection, and may also suffer from acute complications, such as hypercalcemia, spine compression by bone metastasis or bleeding. Prolonging survival is also an inherent expectation for all patients. Addressing the above needs is crucial in all patients with HNC, and especially in those with recurrent and/or metastatic (RM) disease. However, research on how to address patients' needs in RM-HNC remains scarce. This paper defines patients' needs for RM HNC and presents an Expert Opinion on how to address them, proposing also some lines of research | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Head and neck cancer | |
| 650 | 4 | |a Patients’ needs | |
| 650 | 4 | |a Quality of life | |
| 650 | 4 | |a Symptoms | |
| 700 | 1 | |a Mesía, Ricard |e verfasserin |4 aut | |
| 700 | 1 | |a Falco, Agustin |e verfasserin |4 aut | |
| 700 | 1 | |a Hsieh, Jason Chia-Hsun |e verfasserin |4 aut | |
| 700 | 1 | |a Yokota, Tomoya |e verfasserin |4 aut | |
| 700 | 1 | |a Saada-Bouzid, Esma |e verfasserin |4 aut | |
| 700 | 1 | |a Schmitz, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Elicin, Olgun |e verfasserin |4 aut | |
| 700 | 1 | |a Giacomelli, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Bossi, Paolo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Critical reviews in oncology/hematology |d 1996 |g 157(2021) vom: 30. Jan., Seite 103200 |w (DE-627)NLM012606006 |x 1879-0461 |7 nnns |
| 773 | 1 | 8 | |g volume:157 |g year:2021 |g day:30 |g month:01 |g pages:103200 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.critrevonc.2020.103200 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 157 |j 2021 |b 30 |c 01 |h 103200 | ||